InMed Pharmaceuticals Analysis
InMed Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of InMed Pharmaceuticals otc analysis is to determine its intrinsic value, which is an estimate of what InMed Pharmaceuticals is worth, separate from its market price. There are two main types of InMed Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect InMed Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of InMed Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The InMed Pharmaceuticals otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. InMed Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. InMed OTC Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and InMed Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
InMed |
InMed OTC Stock Analysis Notes
The company recorded a loss per share of 0.05. InMed Pharmaceuticals had not issued any dividends in recent years. The entity had 1:15 split on the 6th of July 2020. InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada. INMED PHARMACEUTICALS operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for InMed Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about InMed Pharmaceuticals call Craig Schneider at 604 669 7207 or check out http://www.inmedpharma.com.InMed Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. InMed Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding InMed Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| InMed Pharmaceuticals is not yet fully synchronised with the market data | |
| InMed Pharmaceuticals has some characteristics of a very speculative penny stock | |
| InMed Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.17 M). | |
| InMed Pharmaceuticals has accumulated about 18.58 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. |
InMed Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate InMed Pharmaceuticals's market, we take the total number of its shares issued and multiply it by InMed Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding InMed Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the InMed Pharmaceuticals information on this page should be used as a complementary analysis to other InMed Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in InMed OTC Stock
If you are still planning to invest in InMed Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InMed Pharmaceuticals' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |